Pancreatic Cancer Research

ResearcherNankai UniversityActive in the last 2 years

Lei Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3494-8161; OpenAlex author ID A5115602218. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. Tryptophan metabolism in pancreatic cancer: A review. First author DOI 10.1097/md.0000000000044904↗
  2. Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer. Last author DOI 10.1080/17435889.2024.2382076↗
  3. Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K/AKT/mTOR pathway in murine models of pancreatic cancer. Co-author DOI 10.1016/j.intimp.2023.110579↗
  4. Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation. Co-author DOI 10.3389/fphar.2022.919035↗
  5. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B. Co-author DOI 10.1007/s00432-020-03384-7↗
  6. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001464↗
  7. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer. First author DOI 10.1016/j.biopha.2019.108952↗
  8. Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages. Co-author DOI 10.1016/j.jphs.2018.07.007↗
  9. Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway. Co-author DOI 10.18632/oncotarget.12391↗
  10. Resveratrol plays dual roles in pancreatic cancer cells. Co-author DOI 10.1007/s00432-014-1624-4↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ximo Wang · 4 shared papers, 2018–2025 · strength 0.71
  2. Lihua Cui · 3 shared papers, 2019–2023 · strength 0.42
  3. Yifei Gao · 1 shared paper, 2025 · strength 0.42
  4. Caixia Li · 2 shared papers, 2020–2023 · strength 0.33
  5. Botao Wang · 3 shared papers, 2018–2020 · strength 0.28
  6. Xinsheng Xu · 1 shared paper, 2023 · strength 0.22
  7. Yinan Yang · 3 shared papers, 2014–2021 · strength 0.21
  8. Mengmeng Zhu · 3 shared papers, 2014–2021 · strength 0.21
  9. Zhi Qi · 3 shared papers, 2014–2021 · strength 0.21
  10. Shuhui Li · 1 shared paper, 2024 · strength 0.21
  11. Shukun Zhang · 2 shared papers, 2019–2020 · strength 0.21
  12. Jing Li · 2 shared papers, 2016–2021 · strength 0.17
  13. Chongyang Qiu · 2 shared papers, 2018–2019 · strength 0.17
  14. Qi Zhang · 2 shared papers, 2018–2019 · strength 0.17
  15. Wencong Tian · 2 shared papers, 2014–2021 · strength 0.16
  16. Hongbo Zhang · 1 shared paper, 2022 · strength 0.15
  17. Xuanming Liu · 1 shared paper, 2022 · strength 0.15
  18. Yan Wang · 1 shared paper, 2022 · strength 0.15
  19. Jie Liu · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.